Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon-alpha as an immunotherapeutic protein.

Diana L Brassard1, Michael J Grace, Ronald W Bordens

  • 1Bioanalytical Development, Schering-Plough Research Institute, Union, New Jersey 07083, USA.

Journal of Leukocyte Biology
|April 3, 2002
PubMed
Summary

Interferon-alpha (IFN-alpha) is a clinically effective immunotherapeutic drug for viral and cancer diseases. It regulates cytokines to enhance innate and adaptive immune responses for effective host defense.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemias.

Leukemia & lymphoma·2012
Same author

Glycine to glutamic acid misincorporation observed in a recombinant protein expressed by Escherichia coli cells.

Protein science : a publication of the Protein Society·2012
Same author

Evaporative light scattering detection based HPLC method for the determination of polysorbate 80 in therapeutic protein formulations.

Journal of chromatographic science·2012
Same author

Antibody-unfolding and metastable-state binding in force spectroscopy and recognition imaging.

Biophysical journal·2010
Same author

A tris (2-carboxyethyl) phosphine (TCEP) related cleavage on cysteine-containing proteins.

Journal of the American Society for Mass Spectrometry·2010
Same author

Characterization of S-thiolation on secreted proteins from E. coli by mass spectrometry.

Rapid communications in mass spectrometry : RCM·2009

Area of Science:

  • Immunology
  • Virology
  • Oncology

Background:

  • Interferon-alpha (IFN-alpha) has been a clinically effective antiviral and antineoplastic therapeutic for over 16 years.
  • Evidence supports IFN-alpha's role as an immunotherapeutic agent, modulating immune responses against diseases.

Purpose of the Study:

  • To review the current understanding of IFN-alpha as an immunoregulatory protein.
  • To discuss the application of IFN-alpha as an immunotherapeutic for antineoplastic and antiviral diseases.

Main Methods:

  • Review of in vitro laboratory studies.
  • Analysis of clinical evidence and outcomes.
  • Examination of IFN-alpha's effects on cytokine regulation and immune cell populations.

Main Results:

Related Experiment Videos

  • IFN-alpha regulates diverse cytokines and receptors, priming the host immune response.
  • It stimulates innate cell-mediated immunity and facilitates the transition to adaptive immunity.
  • IFN-alpha promotes CD8+ T-cell responses and maintains CD4+ Th1 cell balance.

Conclusions:

  • IFN-alpha is a key immunoregulatory protein with significant therapeutic potential.
  • Its ability to modulate both innate and adaptive immunity makes it valuable for treating viral and neoplastic diseases.